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Abstract
Background
The American Diabetes Association recently included glycated hemoglobin in the diagnos-
tic criteria for diabetes, but research on the utility of this biomarker in Southeast Asians is
scant. The aim of this study was to evaluate the association between percent HbA1c and in-
cident diabetes in an Asian population of adult men and women without reported diabetes.
Methods
Data analysis of 5,770 men and women enrolled in the Singapore Chinese Health Study
who provided a blood sample at the follow-up I visit (1999–2004) and had no cancer and no
reported history of diabetes or cardiovascular disease events. Diabetes was defined as
self-report of physician diagnosis, identified at the follow-up II visit (2006–2010).
Results
Hazard ratios (and 95% confidence intervals) for incident diabetes by 5 categories of HbA1c
were estimated with Cox regression models and continuous HbA1c with cubic spline analysis.
Compared to individuals with an HbA1c 5.7% (39 mmol/mol), individuals with HbA1c
5.8–5.9% (40–41 mmol/mol), 6.0–6.1% (42–43 mmol/mol), 6.2–6.4% (44–47 mmol/mol),
and 6.5% (48 mmol/mol) had significantly increased risk for incident diabetes during fol-
low-up. In cubic spline analysis, levels below 5.7% HbA1c were not significantly associated
with incident diabetes.
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Conclusions
Our study found a strong and graded association with HbA1c 5.8% and above with incident
diabetes in Chinese men and women.
Introduction
After critical review by an expert committee, the American Diabetes Association recently rec-
ommended the inclusion of percent glycated hemoglobin (HbA1c %) in the diagnostic criteria
for diabetes [1,2]. HbA1c reflects average glucose concentrations over the previous 2–3 months
and is predictive of microvascular complications in diabetes [1]. Advantages of HbA1c include
it being a standardized test not requiring individuals to be of fasting state, nor does it impose
lengthy time commitment or great discomfort [3]. This may lend the test to be used in lieu of
other glycemic testing methods, particularly in settings not amenable to individual behavior
or temperament.
Evaluation of HbA1c across populations is necessary to further understanding, especially
with the global increases in diabetes and pre-diabetes [4]. Level of HbA1c is shown to predict
incident diabetes in a variety of populations, but there is limited data from Southeast Asian
populations [5]. Total diabetes cases and disease rates have reached epidemic proportions in
Asia.4 Compared to persons of European decent, individuals from Asia tend to develop diabe-
tes at a younger age and lower level of body mass index (BMI) [6]. This indicates there is a
continuum of risk for developing the disease at levels not typically thought detrimental to
Western populations. Across ethnicities in Asia, differences in average HbA1c level have been
identified [7]. Thus, it is important to characterize the relationship between HbA1c and inci-
dent diabetes in Asian populations, particularly at levels of HbA1c considered “prediabetic” by
Western standards.
Demarcation of increased risk for diabetes according to HbA1c level has clinical impor-
tance, especially in Southeast Asian adults where there is a dearth of literature on the topic, yet
the population is high risk. The aim of this study was to examine the association of HbA1c and
incident diabetes in this Chinese population in Southeast Asia by a priori interval of HbA1c
and also by continuous HbA1c value to better illustrate the HbA1c-diabetes risk dynamic in
this population.
Methods
The Singapore Chinese Health Study (SCHS) cohort was drawn from men and women, aged
45 to 74 years, who identified with one of the major dialect groups (Hokkien or Cantonese) of
Chinese in Singapore. From April 1993 through December 1998, 63,257 individuals were en-
rolled, approximately 85% of the eligible subjects who were invited to participate, and followed
prospectively. Participants were residents of government-built housing estates, where 86% of
the Singaporean population resided during the enrollment period. Subjects provided written
informed consent with the completion of an in-person interview conducted in the participant’s
home that included questions on demographics, height and weight, use of tobacco, usual physi-
cal activity, menstrual and reproductive history (women only), medical history, and a 165-item
food frequency questionnaire assessing usual dietary intake for the previous year. Approval of
the study protocol and procedure of consent were granted by the Institutional Review Boards
at the National University of Singapore, University of Pittsburgh and the University of
Minnesota.
HbA1c and Incident Diabetes
PLOS ONE | DOI:10.1371/journal.pone.0119884 March 16, 2015 2 / 11
supported by NIH grant R01 DK080720. MB was
supported by the NIH Training Grant T32HL007779
to conduct the current work (URL: http://www.nih.gov/
science/). The funders had no role in study design,
data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
Collection of participant characteristics
Subjects were followed-up in 1999–2004 with a telephone interview (F1), during which subjects
were asked to update their baseline interview information. Individuals were queried regarding
smoking status (commencement and cessation) and regular consumption of alcoholic bever-
ages (beer, wine, western hard liquor and Chinese hard liquor). Participants were asked to
choose from eight frequency categories and four portion sizes and levels of alcohol intake were
expressed in units of ‘drinks’ per week to facilitate comparison with western populations. One
drink was defined as 375 ml of beer (13.6 g of ethanol), 118 ml of wine (11.7 g of ethanol), and
30 ml of western or Chinese hard liquor (10.9 g of ethanol). Other risk factors assessed at F1 in-
clude educational attainment (highest level completed), self-reported hypertensive status (yes/
no) as diagnosis by physician, and body mass index (BMI) calculated with self-reported height
(m) and weight (kg) as kg/meter-squared. For this analysis, participant characteristics reflect
those given at the F1 interview.
HbA1c analysis
Red-blood cells (RBCs) were isolated from whole blood and frozen until analysis that was per-
formed at University of Minnesota. Percentage of HbA1c was analyzed in a Clinical Laboratory
Improvement Amendments-certified laboratory using an automated high-performance liquid
chromatography method where whole blood samples are treated with ethylenediaminetetra-
acetic acid on a Tosoh G7 hPLC Glycohemoglobin Analyzer (Tosoh Medics, Inc., San Fran-
cisco, California). Using the standards developed in the National Glycohemoglobin
Standardization Program, this method for assessing the percentage of HbA1c was calibrated to
the reference range of HbA1c 4.3%-6.0% with a coefficient of variation range 1.4%-1.9% [8].
Diabetes assessment
Individuals were evaluated for diabetes status at baseline, F1, and F2. Self-reported diabetes as
diagnosed by physician was assessed with the following question: “Have you been told by a
doctor that you have diabetes (high blood sugar)?” If yes: “Please also tell me the age at which
you were first diagnosed?” Participants with a history of diagnosed diabetes at baseline or F1
were excluded from analysis. Individuals were considered to have incident diabetes if they re-
ported developing diabetes anytime between the F1 interview and F2 interview. A validation
study of the incident diabetes mellitus cases in the original cohort used 2 different methods,
previously reported by Odegaard et al [9,10].
Formation of analysis cohort
The formation of the current analytic sample is summarized in Fig. 1. Of the 54, 243 partici-
pants who were alive and participated at F1, a total of 28, 346 individuals provided consent to
collect blood samples (roughly a consent rate of 65%). Participants in this analysis were indi-
viduals with no history of cancer at baseline or F1, and did not report a history of diabetes or
cardiovascular disease at either interview. They were randomly selected and frequency matched
to incident cases of type 2 diabetes from the full study population occurring between baseline
and the follow-up interview on age (±2), time of blood draw, gender, and dialect (N = 7,377).
This sub-sample was established in order to serve as a non-diabetic comparison group in future
SCHS Genome Wide Association analyses of incident diabetes cases occurring prior to F1.
This analytic sub-sample is slightly younger, more male, and reported more smoking, but is
similar in respect to dialect, alcohol consumption, education, and BMI to their contemporaries
participating at F1 who did not report diabetes, cardiovascular disease, or cancer. Linkage with
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the nation-wide registry of birth and death in Singapore reported 620 individuals from this
sample died before a second follow-up interview that occurred in 2006–2010 (F2). These indi-
viduals tended to be older, male, of lower educational status, hypertensive, current smokers,
and heavier consumers of alcohol compared to our final analysis cohort. Additionally, approxi-
mately 987 individuals from this sample could not be located to participate in the F2 interview
as of the time of this analysis. These individuals tended to be older, reported a positive history
of hypertension at F1, and were of lower educational attainment compared to those followed
through the F2 interview. Both the group of individuals who died before F2 and those lost to
the F2 interview had a higher average percent HbA1c compared to those who were in the final
analytic sample. All participants with blood samples drawn and analyzed for HbA1c who par-
ticipated in the F2 interview were included in this analysis regardless of HbA1c status for a
final analytic sample of N = 5,770.
Statistical analysis
HbA1c was divided into five categories to align with the distribution of the data, clinical rele-
vance, and cut-points used in the literature. The categories were 5.7%, 5.8–5.9%, 6.0–6.1%,
6.2–6.4%, and 6.5%. Smoking status was classified as “never smoked”, “former smoker”, and
“current smoker”. Alcohol was modeled continuously, average number of drinks consumed
per week. In this analysis, education was characterized into 3 groups: no formal education; pri-
mary schooling; and secondary school or beyond. Participant characteristics were calculated
across categories. Means and standard deviations were derived for continuous variables and
proportions were calculated for categorical variables. Diabetes hazard ratios were calculated by
HbA1c level. Crude and adjusted hazard ratios and 95% confidence intervals (CIs) were esti-
mated with Cox proportional-hazards models. Traditionally a lower HbA1c level is beneficial
in relation to development of diabetes and while HbA1c of 5.7% represents the lower bound
for prediabetes diagnosis by the American Diabetes Association (ADA) criterion the HbA1c
category of 5.7% was chosen as the reference category to provide a stable comparison group
(cases> 10). The remaining categories of elevated yet normal HbA1c allow for comparison
with other ethnic populations on diabetes risk in individuals with prediabetic levels of glucose
and so potential clinically relevant ranges below the threshold for diabetes could be examined,
unique to this population. The main effect crude model included only the HbA1c level. Adjust-
ed models were constructed in this manner: Model 1 was adjusted for age, gender, dialect, and
interview year. Model 2 was adjusted further for education, smoking status, and alcohol con-
sumption. Model 3 was adjusted for all previous covariates plus BMI and hypertension status.
Fig 1. Timeline and assembly of sub-sample, The Singapore Chinese Health Study.
doi:10.1371/journal.pone.0119884.g001
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When the above models included additional covariates including a baseline dietary pattern
score (vegetable-fruit-soy or dim-sum-meat) [11] and average moderate (e.g., brisk walking, bi-
cycling on level ground) and strenuous (e.g., jogging, bicycling on hills, tennis) physical activity
per week, the results were not meaningfully changed. Therefore, the results with these addition-
al adjustment variables were not presented. A variable for the squared HbA1c percentage was
created for the assessment of quadratic relationship between HbA1c and risk of diabetes inci-
dence. Restricted cubic spline analysis was performed centering the spline at HbA1c of 5.7%.
Contributed person-time to the study was calculated as the duration from age at blood draw to
age of reported type 2 diabetes diagnosis or age at administration of F2 interview (i.e., censor-
ing date). Age and sex standardized incidence rates were calculated for each HbA1c level by
categorizing age into three groups,59, 60–69, and70 years old and calculating sex specific
crude incidence rates for each age group (cases/person years) according to the person-time,
gender, and age distribution of the SCHS. To investigate if HbA1c levels differed across levels
of sex, smoking, BMI, or age, separate multiplicative interactions were tested by adding product
terms to the proportional hazards model. The proportional hazards assumption was assessed
by HbA1c category and no violations were detected. Sensitivity analysis was also performed, by
excluding observation in the first 3 years post blood draw for all 5,770 individuals, for purposes
of accounting for possible sub-clinical disease or underlying poor health. Model discrimination
was evaluated using Harrell’s C statistic. Statistical analysis was performed using SAS statistical
software version 9.3 (SAS Institute Inc., Cary, NC) and STATA 12.0 software (StataCorp LP.,
College Station, Texas).
Results
Over 50% of the study population had HbA1c 5.7%. Among the remaining HbA1c categories
the study population distribution in ascending order was 20%, 12%, 7%, and 5%, respectively.
Characteristics of the 5,770 participants analyzed are presented in Table 1. At F1, the sample
average age was 62.9 years with a mean BMI of 22.9 kg/meter-squared. HbA1c was positively
associated with age, BMI, current smoking, and self-reported hypertension. Average weekly al-
cohol consumption was similar across HbA1c categories as was dialect group. Females were
slightly more represented than males across HbA1c categories with the exception of
HbA1c 6.5% where female gender represented less than half of the category. HbA1c was in-
versely associated with highest educational attainment.
The average follow-up time was 5.2 years. Individuals with HbA1c 6.5% had an average
follow-up time of 4.7 years and 20% of this HbA1c category (n = 63) self-reported diagnosis of
diabetes at F2. There were 114 incident cases of diabetes during the 29,753 years of total fol-
low-up time, corresponding to a crude incidence rate of 383 cases per 100,000 person years.
The overall age and sex standardized incidence rate was 415 cases per 100,000 person years.
Presented in Table 2 are fully-adjusted hazard ratios (HR) with 95% confidence intervals and
adjusted incidence rates according to HbA1c level. The HR for diabetes increased with higher
HbA1c%. Compared to individuals with an HbA1c 5.7% (39 mmol/mol), individuals with
HbA1c 5.8–5.9% (40–41 mmol/mol), 6.0–6.1% (42–43 mmol/mol), 6.2–6.4% (44–47 mmol/
mol), and 6.5% (48 mmol/mol) had 4-, 5-, 8-, and 60-fold increase in risk for developing
diabetes, respectively, after adjustment. The HRs for incident diabetes for each HbA1c category
were attenuated but still strongly significant as the models were subsequently adjusted for po-
tential confounders. The largest attenuation was observed for those with HbA1c 6.5%. The
test for a quadratic association between HbA1c % and incident diabetes was statistically signifi-
cant (p<0.001). Adjusted results from cubic spline regression are presented in Fig. 2. In spline
analysis excluding individuals with HbA1c values in the lower and upper 5th percent
HbA1c and Incident Diabetes
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(HbA1c< 4.9% and HbA1c 6.5%), risk of diabetes significantly increases for
HbA1c> 5.7%, after adjusting for age, gender, and dialect group. Individuals with an
HbA1c< 5.7% had reduced risk of incident diabetes compared to individuals with HbA1c of
5.7%, however the confidence limits span HR = 1. Formal tests of interaction were not signifi-
cant for any characteristics (p> 0.10). Upon exclusion of observation of the first three years
post blood draw the results did not substantively change, however the HRs in the two highest
HbA1c categories did attenuate (shown in Table 2). These attenuated results should be inter-
preted with caution given the decrease in both sample size and amount of cases.
Discussion
In this study, Singaporean adult men and women with elevated, but not overtly diabetic levels
of HbA1c were at increased risk for developing diabetes during follow-up. When looking at the
spectrum of HbA1c values considered nondiabetic, there was strong, positive association with
HbA1c values above 5.7%. These results are important, considering the difference in risk for
developing diabetes by race and ethnicity [12]. Indeed, these results align with previous studies
Table 1. Participant characteristics diabetes according to category of glycated hemoglobin (HbA1c%), The Singapore Chinese Health Study.
HbA1c (%) Category Excluded
 5.7 5.8–5.9 6.0–6.1 6.2–6.4  6.5 P for
trend
Died before
F2
Lost to
follow-up
Number 3262 1127 667 397 317 620 987
HbA1c % 5.4 (0.27) 5.8 (0.05) 6.0 (0.05) 6.3 (0.08) 7.3 (1.23) < 0.001 5.96 (0.85) 5.90 (0.85)
Number of cases 11 16 13 11 63 < 0.001 — —
Age 62.5 (7.1) 63.1 (7.0) 63.5 (7.0) 64.5 (7.0) 64.4 (7.6) < 0.001 68.8 (7.0) 64.0 (7.5)
Female (%) 53 52 54 56 44 0.22 40.2 55.7
Cantonese dialect (%) 49 50 49 54 48 0.57 41.0 50.8
Education (%) < 0.001
< Primary
School
20 23 24 23 20 29.4 22.5
Primary
schooling
45 43 44 48 53 51.6 52.3
 Secondary
school
35 34 32 29 27 19.0 25.2
Smoking status (%) < 0.001
Never 70 66 64 64 62 46.1 67.5
Former 16 17 16 15 17 23.1 17.5
Current 14 17 20 21 21 30.8 15.0
Alcoholic drinks/week 1.0 (4.0) 0.9 (3.6) 0.8 (3.4) 1.0 (4.0) 1.1 (4.6) 0.6 1.7 (5.8) 0.8 (4.0)
Physical Activity1 (min/
week)
71.7
(177.1)
61.4
(156.0)
75.8
(192.7)
65.8
(139.8)
67.7
(198.9)
0.6357 NA NA
BMI2 (kg/m^2) 22.5 (3.3) 23.0 (3.3) 23.3 (3.6) 24.3 (3.5) 24.3 (3.4) < 0.001 22.9 (3.9) 23.0 (3.5)
Hypertensive (%) 29 32 37 42 44 < 0.001 41.9 40.2
1Physical activity is the average min/week of combined moderate and strenuous activity
2Body mass index
NA: Not applicable to estimate due to missing data
Continuous variables are means (SD)
Categorical variables are % within column
P for trend is testing for a linear trend across HbA1c category
doi:10.1371/journal.pone.0119884.t001
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comprised of various race/ethnicities [5,13–15]. In distinct populations of US and European
adult men and women, HbA1c strongly predicts incident diabetes [13,15]. In two older healthy
populations of men and women, respectively, baseline HbA1c strongly predicted incident dia-
betes [16,17]. In a French population of adults with impaired fasting plasma glucose (FPG) at
baseline (FPG 6.10 mmol/l), HbA1c predicted diabetes defined by future fasting plasma
Table 2. Incidence rates and hazard ratios (HR) with 95% confidence intervals for incident type 2 diabetes according to category of glycated
hemoglobin (HbA1c%), The Singapore Chinese Health Study.
HbA1c (%) Category
 5.7 5.8–5.9 6.0–6.1 6.2–6.4  6.5
Number 3262 1127 667 397 317
Incident cases (% total) 11 (10) 16 (14) 13 (11) 11 (10) 63 (55)
Years follow-up (average) 16993 (5.2) 5793 (5.1) 3451 (5.2) 2018 (5.1) 1498 (4.7)
Crude incidence rate 65 276 377 545 4206
Standardized incidence rate 65 243 366 579 4935 Harrell’s C
Unadjusted HR model 1.0 4.30 (2.00, 9.27) 5.82 (2.61, 12.98) 8.54 (3.70, 19.71) 66.1 (34.8, 125.4) 0.860
Final adjusted HR model 1.0 4.17 (1.93, 9.00) 5.49 (2.45, 12.30) 8.25 (3.54, 19.25) 59.9 (31.1, 115.3) 0.876
Followed  3 years HR model 1.0 3.57 (1.56, 8.15) 5.11 (2.19, 11.90) 5.11 (1.92, 13.63) 38.3 (18.8, 78.0) 0.863
Crude incidence rate: per 100,000 person years
Standardized incidence rate: per 100,000 person years according to the gender, age and follow-up time distribution of the SCHS
Final adjusted model: Adjusted for age, gender, dialect, interview year, educational status, smoking status, average weekly alcohol intake BMI, and
hypertensive status
Followed  3 years: analysis when excluding the first three years post blood-draw
doi:10.1371/journal.pone.0119884.t002
Fig 2. Cubic spline of the association between glycated hemoglobin (HbA1c%) and self-reported
incident diabetes, adjusted for age, gender, and dialect, The Singapore Chinese Health Study. The
hazard ratio (HR) is per each absolute increase of 1 percentage point in the glycated hemoglobin value at
baseline. The shaded area is the 95% confidence interval from the restricted-cubic-spline model. The HR
scale is logarithmic, the model is centered at the mean/median (5.7%), and the plot was truncated at the 5th
and 95th percentiles of glycated hemoglobin (4.9% and 6.5%, respectively). The hazard ratio was adjusted
for age, gender, and dialect.
doi:10.1371/journal.pone.0119884.g002
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glucose (FPG 7.00 mmol/l) or diabetes medication use [18]. After controlling for baseline
2-hour glucose status, a 1% change in HbA1c was associated with nearly fourfold greater haz-
ards of incident diabetes in a population of adult Hong Kong residents [19]. Notably, research-
ers did not adjust for potential confounders beyond baseline glucose (i.e., hazards unadjusted
for age, sex, BMI, etc.) and participants in the study population of Hong Kong were, on aver-
age, 10 years younger than that of Singapore and naturally at lower risk for diabetes compared
to the older SCHS sample. In a population of Japanese adult men and women, HbA1c indepen-
dently predicted development of diabetes in 7 years of follow-up and an apparent multiplica-
tive interaction between FPG and HbA1c on diabetes diagnosis was observed. This interaction
has not been consistent across studies [18,20,21]. Fasting glucose was not collected during the
F1 exam cycle and we were unable to assess this interaction in our study.
This study is not without limitations. We are not able to evaluate clinical measures such as
lipids, glucose, and insulin levels in this association, as they were not measured. These metabol-
ic risk factors may be related to some of the pathways through which HbA1c may influence di-
abetes, and thus their adjustment may not be prudent. Related, adjustment for lipids has
shown to have minimal effect on hazard ratios when collectively accounting for anthropomet-
ric and blood pressure measures [13,15,18,20,21]. The results from these previous studies sug-
gest the potential confounding by unmeasured lipid values would not have a significant impact
on the interpretation of our findings given the magnitude of our point estimates. Further, we
found no meaningful change to our results after adjustment for regular diet and physical activi-
ty level, both traditional precedents to lipid levels and strong predictors of incident diabetes.
We were only able to measure HbA1c once and while HbA1c reflects glycemia of the prior 2–3
months and is often used in the clinical setting, how representative this one-time measure is of
an individual over extended time periods is less clear. HbA1c test results are impacted by the
presence of blood disorders that shorten red blood cell lifespan or create abnormal structural
changes to hemoglobin, may misclassify gestational diabetes cases compared to oral glucose
tolerance testing (OGTT), and differ by race regardless of diabetes status; in the United States,
whites are found to have the lowest mean HbA1c compared to African Americans or Hispanics
[22–25]. Thus, assay results require careful interpretation for particular populations. Lifestyle
factors of smoking status and alcohol use were self-reported, leading to residual confounding
and misclassification, though in a prospective study such as this the misclassification is most
likely non-differential. The reference group was chosen in part due to the limited number of di-
abetes cases that developed in individuals with HbA1c 5.7%. We were unable to clearly eval-
uate the association between HbA1c and incident disease at HbA1c levels below HbA1c 5.7%.
Diabetes ascertainment in this population was by self-report of physician diagnosis, thus indi-
viduals with HbA1c values deemed diabetic by recent ADA standards were considered to be
disease free at baseline. The highest category of percentage HbA1c represent individuals who
would be considered diabetic at the start of follow-up by ADA standards. In addition to elevat-
ed HbA1c levels, these individuals were of older age and greater BMI at the start of follow-up
and the relatively low percentage of individuals in this HbA1c category who go on to self-report
diabetes status at F2 is of concern. Potentially this low reporting of disease may be a result of a
myriad of factors including differential utilization of preventive health services by age, physi-
cian’s use of non-ADA diagnostic standards (i.e., excluding the use of OGTT and HbA1c val-
ues from diagnostic decision making), or participant misreport of diabetes status [26,27]. We
aimed to address the claim that individuals potentially with underlying diabetes would be iden-
tified in the first three years post blood-draw, leading to spurious results. The HRs in the lower
HbA1c groups remained relatively stable with the exclusion of the first three years of observa-
tion time. The corollary observed in the highest HbA1c group with this follow-up time exclu-
sion, while overtly noticeable, does not influence the interpretation of the original results.
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Future studies on similar populations should continue to hone the appropriate HbA1c cut-
point for diagnosis of type 2 diabetes and reasons why diabetes may be going undiagnosed.
The strengths of this study should be considered when interpreting our findings. This analy-
sis was able to evaluate a spectrum of HbA1c values below the ADA threshold for diagnosing
diabetes. This is a large Chinese population in which participant information was collected
through detailed in-person interviews, with high participant response rates, diabetes case vali-
dation, and adjustment for potential confounders. The population of Singapore has experi-
enced rapid industrialization and accelerated advances in medical care over the last 50 years
since its independence, resulting in a relatively high standard of living. This offers a unique op-
portunity to study a population on the leading edge of westernization of diet and lifestyle still
within Asia. The participants in this study are representative of the source population support-
ing the results observed being applicable to individuals of Hokkien and Cantonese descent liv-
ing in this part of Southeast Asia.
In this population-based study of nondiabetic Singapore Chinese adult men and women,
glycated hemoglobin level, below the diagnostic threshold for diabetes (HbA1c 5.8%-6.4%), in-
dependently predicts incident diabetes after adjustment for potential confounding factors. This
study provides support for a continuum of risk for developing diabetes at HbA1c % levels
below 6.5%. Therefore, the results of this study support the clinically established HbA1c values
for individuals at increased risk for diabetes in Western populations.
Acknowledgments
No potential conflicts of interest relevant to this article were reported for any author. Mr. Mi-
chael P. Bancks is the guarantor of this work, had full access to the data in this analysis, and
takes responsibility for the integrity of the data and the accuracy of the data analysis. Research
reported in this publication was partially supported by the National Heart, Lung, And Blood
Institute of the National Institutes of Health under Award Number T32HL007779. The content
is solely the responsibility of the authors and does not necessarily represent the official views of
the National Institutes of Health. Authors thank Siew-Hong Low of the National University of
Singapore for supervising the field work of the Singapore Chinese Health Study, and Kazuko
Arakawa and Renwei Wang for the development and maintenance of the cohort study data-
base. We also thank Faye L. Lopez of the University of Minnesota for the translation of and as-
sistance in spline analysis. Finally, we acknowledge the founding, long-standing Principal
Investigator of the Singapore Chinese Health Study – Mimi C. Yu.
Author Contributions
Analyzed the data: MB AO. Contributed reagents/materials/analysis tools: MG. Wrote the
paper: MB AOWK JY MP.
References
1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. Janu-
ary 2010 33:S62–S69. doi: 10.2337/dc10-S062 PMID: 20042775
2. International Expert Committee. International Expert Committee report on the role of the A1C assay in
the diagnosis of diabetes. Diabetes Care. 2009; 32(7):1327–1334.
3. Little RR. Glycated hemoglobin standardization—National Glycohemoglobin Standardization Program
(NGSP) perspective. Clin Chem Lab Med. 2003; 41:1191–1198. PMID: 14598869
4. International Diabetes Federation. IDF Diabetes Atlas, 6th edn. Brussels, Belgium: International Dia-
betes Federation, 2013.
HbA1c and Incident Diabetes
PLOS ONE | DOI:10.1371/journal.pone.0119884 March 16, 2015 9 / 11
5. Zhang X, Gregg EW,Williamson DF, Barker LE, ThomasW, Bullard KM, et al. A1C level and future risk
of diabetes: a systematic review. Diabetes Care. 2010 Jul; 33(7):1665–73. doi: 10.2337/dc09-1939
PMID: 20587727
6. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in
Asia. Lancet. 2006 Nov 11; 368(9548):1681–8. Review. PMID: 17098087
7. Venkataraman K, Kao SL, Thai AC, Salim A, Lee JJ, Heng D, et al. Ethnicity modifies the relation be-
tween fasting plasma glucose and HbA1c in Indians, Malays and Chinese. Diabet Med. 2012 Jul; 29
(7):911–7.
8. Steffes MW, Cleary P, Goldstein D, Little R, Wiedmeyer HM, Rohlfing C, et al. Hemoglobin A1c mea-
surements over nearly two decades: sustaining comparable values throughout the Diabetes Control
and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study. Clin
Chem. 2005; 51(4):753–758. PMID: 15684277
9. Odegaard AO, Pereira MA, KohWP, Arakawa K, Lee HP, Yu MC. Coffee, tea, and incident type 2 dia-
betes: the Singapore Chinese Health Study. Am J Clin Nutr. 2008; 88(4):979–985. PMID: 18842784
10. Odegaard AO, KohWP, Arakawa K, Yu MC, Pereira MA. Soft Drink and Juice Consumption and Risk
of Physician-diagnosed Incident Type 2 Diabetes: The Singapore Chinese Health Study. Am J Epide-
miol. 2010 Mar; 171(6):701–708. doi: 10.1093/aje/kwp452 PMID: 20160170
11. Odegaard AO, KohWP, Butler LM, Duval S, Gross MD, Yu MC, et al. Dietary patterns and incident type
2 diabetes in chinese men and women: the singapore chinese health study. Diabetes Care. 2011 Apr;
34(4):880–5. doi: 10.2337/dc10-2350 PMID: 21330641
12. WHOExpert Consultation. Appropriate body-mass index for Asian populations and its implications for
policy and intervention strategies. Lancet. 2004 Jan 10; 363(9403):157–63. PMID: 14726171
13. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, et al. Glycated hemoglobin, di-
abetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010 Mar 4; 362(9):800–11. doi:
10.1056/NEJMoa0908359 PMID: 20200384
14. Ramachandran A, Snehalatha C, Samith Shetty A, Nanditha A. Predictive value of HbA1c for incident
diabetes among subjects with impaired glucose tolerance—analysis of the Indian Diabetes Prevention
Programmes. Diabetic Medicine. 2012 Jan; 29(1):94–8. doi: 10.1111/j.1464-5491.2011.03392.x PMID:
21790773
15. Chamnan P, Simmons RK, Forouhi NG, Luben RN, Khaw KT, Wareham NJ, et al. Incidence of type 2
diabetes using proposed HbA1c diagnostic criteria in the european prospective investigation of cancer-
norfolk cohort: implications for preventive strategies. Diabetes Care. 2011 Apr; 34(4):950–6.
16. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ. Utility of hemoglobin A1c in predicting dia-
betes risk. J Gen Intern Med. 2004 Dec; 19(12):1175–80. PMID: 15610327
17. Pradhan AD, Rifai N, Buring JE, Ridker PM. Hemoglobin A1c predicts diabetes but not cardiovascular
disease in nondiabetic women. Am J Med. 2007 Aug; 120(8):720–7. PMID: 17679132
18. Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, et al; DESIR Study Group. Use of
HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological
Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care. 2006 Jul; 29(7):1619–25. PMID:
16801588
19. Law LS, Tso AW, Tam S, Wat NM, Cheung BM, Lam KS. Haemoglobin A1c is superior to fasting glu-
cose in predicting the incidence of diabetes over 8 years among Chinese. Diabetes Res Clin Pract.
2011 Feb; 91(2):e53–6. doi: 10.1016/j.diabres.2010.11.014 PMID: 21185103
20. Heianza Y, Arase Y, Fujihara K, Tsuji H, Saito K, Hsieh SD, et al. Screening for pre-diabetes to predict
future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon
Hospital Health Management Center Study 4 (TOPICS 4). Diabet Med. 2012 Sep; 29(9):e279–85. doi:
10.1111/j.1464-5491.2012.03686.x PMID: 22510023
21. Sato KK, Hayashi T, Harita N, Yoneda T, Nakamura Y, Endo G, et al. Combined measurement of fast-
ing plasma glucose and A1C is effective for the prediction of type 2 diabetes: the Kansai Healthcare
Study. Diabetes Care. 2009 Apr; 32(4):644–6. doi: 10.2337/dc08-1631 PMID: 19131461
22. HermanW, Cohen R. Racial and Ethnic Differences in the Relationship between HbA1c and Blood Glu-
cose: Implications for the Diagnosis of Diabetes. The Journal of clinical endocrinology and metabolism.
2012; 97(4):1067–72. doi: 10.1210/jc.2011-1894 PMID: 22238408
23. Boltri JM, Okosun IS, Davis-Smith M, Vogel RL. Hemoglobin A1c levels in diagnosed and undiagnosed
black, Hispanic, and white persons with diabetes: results from NHANES 1999–2000. Ethn Dis. 2005;
15(4):562–567. PMID: 16259477
24. Hughes RC, Moore MP, Gullam JE, Mohamed K, Rowan J. An early pregnancy HbA1c> = 5.9% (41
mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnan-
cy outcomes. Diabetes Care. 2014; 37(11):2953–2959. doi: 10.2337/dc14-1312 PMID: 25190675
HbA1c and Incident Diabetes
PLOS ONE | DOI:10.1371/journal.pone.0119884 March 16, 2015 10 / 11
25. Sevket O, Sevket A, Ozel A, Dansuk R, Kelekci S. The use of HbA1c as an aid in the diagnosis of gesta-
tional diabetes mellitus. J Obstet Gynaecol. 2014; 34(8):690–692. doi: 10.3109/01443615.2014.
925855 PMID: 25340849
26. George PP, Heng BH, De Castro Molina JA, Wong LY, Wei Lin NC, Cheah JT. Self-reported chronic
diseases and health status and health service utilization—results from a community healthsurvey in
Singapore. Int J Equity Health. 2012 Aug 16;11:44.
27. Ministry of Health, Singapore. MOHClinical Practice Guidelines March 1/2014; Diabetes Mellitus (Sum-
mary Booklet). Singapore: Ministry of Health, 2014.
HbA1c and Incident Diabetes
PLOS ONE | DOI:10.1371/journal.pone.0119884 March 16, 2015 11 / 11
